Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A‐I [Human]) to Enhance Cholesterol Efflux Capacity

por Gille, Andreas, Duffy, Danielle, Tortorici, Michael A., Wright, Samuel D., Deckelbaum, Lawrence I., D'Andrea, Denise M.
Publicado 2018

Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States

por Ryan, Charles J., Ke, Xuehua, Lafeuille, Marie-Hélène, Romdhani, Hela, Kinkead, Frederic, Lefebvre, Patrick, Petrilla, Allison, Pulungan, Zul, Kim, Seung, D'Andrea, Denise M., Francis, Peter, Freedland, Stephen J.
Publicado 2021

Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial

por Tricoci, Pierluigi, D’Andrea, Denise M, Gurbel, Paul A, Yao, Zhenling, Cuchel, Marina, Winston, Brion, Schott, Robert, Weiss, Robert, Blazing, Michael A, Cannon, Louis, Bailey, Alison, Angiolillo, Dominick J, Gille, Andreas, Shear, Charles L, Wright, Samuel D, Alexander, John H
Publicado 2015

Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Isc...

por Michael Gibson, C., Korjian, Serge, Tricoci, Pierluigi, Daaboul, Yazan, Yee, Megan, Jain, Purva, Alexander, John H., Steg, P. Gabriel, Lincoff, A. Michael, Kastelein, John J.P., Mehran, Roxana, D’Andrea, Denise M., Deckelbaum, Lawrence I., Merkely, Bela, Zarebinski, Maciej, Ophuis, Ton Oude, Harrington, Robert A.
Publicado 2016